RFK Jr Flu Vaccine: Australia Concerns?
- Kennedy Jr.'s overhaul of the Advisory Committee for Immunization Practices (ACIP) is raising concerns about vaccine misinformation and access.
- Thiomersal has long been a target of anti-vaccine groups, despite scientific evidence confirming its safety in preventing bacterial and fungal contamination.
- dr.Sean O'Leary, chair of the American Academy of Pediatrics Committee on Infectious Diseases, called the new ACIP an "embarrassment." Dr.
Robert F. Kennedy Jr.’s stance on vaccines is sparking global concerns, notably regarding influenza vaccines adn teh preservative thiomersal. His influence on the Advisory Committee for Immunization Practices (ACIP) is generating heated debate,as the panel’s decision could impact vaccine access and costs.While Australia largely avoids thiomersal, experts are worried about the potential spread of misinformation and the impact on vaccination efforts. This article, available via News Directory 3, dissects the situation, exploring the science behind thiomersal and its use in various countries. Learn how RFK jr.’s actions might affect vaccine availability and funding. Discover what’s next for vaccines and the battle against misinformation.
RFK Jr.’s Vaccine Stance: Thiomersal and Global Concerns
Table of Contents
Robert F. Kennedy Jr.’s overhaul of the Advisory Committee for Immunization Practices (ACIP) is raising concerns about vaccine misinformation and access. The panel recently voted against influenza vaccines containing thiomersal, a preservative known as thimerosal in the U.S.
Thiomersal has long been a target of anti-vaccine groups, despite scientific evidence confirming its safety in preventing bacterial and fungal contamination. Critics fear the ACIP decision could increase vaccine costs and fuel hesitancy.
dr.Sean O’Leary, chair of the American Academy of Pediatrics Committee on Infectious Diseases, called the new ACIP an “embarrassment.” Dr. Cody Meissner, a pediatrics professor, cast the sole dissenting vote, warning that removing thiomersal could reduce vaccine access and increase costs, with no evidence of harm.
What is Thiomersal?
Thiomersal contains ethylmercury, which differs from the toxic methylmercury. The National Center for Immunisation Research and Surveillance (NCIRS) notes its use since the 1930s in multi-dose vials to prevent contamination.
False claims linking vaccines to autism emerged around the same time as a methylmercury study, falsely conflating the two types of mercury.
Thiomersal in Australia
Australia’s National Immunisation Program does not use thiomersal, except in the Q fever vaccine for those at risk through animal contact.It has not been used in routine childhood vaccines since 2000.
Dr. Gary Grohmann, former head of immunobiology evaluating vaccines at the Therapeutic Goods Governance, said Australia’s vaccine program is largely autonomous from the U.S. Single-dose vaccines reduce contamination risk, and thiomersal was removed as a precaution despite its safety.
Professor Julie Leask,a vaccination social researcher at the University of Sydney,suggests this may have inadvertently “legitimized” concerns about thiomersal’s safety.
Impact of RFK Jr.’s Move
Leask believes the ACIP decision will have limited impact on vaccine availability in Australia. Though, she worries about potential funding cuts for vaccine research involving thiomersal and the spread of misinformation.
“This anti-vax sentiment is now at this very high level in the US government, and that gives it a form of legitimacy that it’s never really had before,” she said.
Grohmann echoed these concerns, emphasizing that disinformation hinders vaccination efforts, potentially leading to outbreaks of preventable diseases.
Combating Misinformation
Leask advises critical evaluation of online information and reliance on authoritative Australian sources like NCIRS and the government.
grohmann highlights the economic benefits of vaccination, estimating $16 saved for every dollar spent, and urges peopel to “listen to experts, not YouTubers.”
Leask anticipates ongoing battles in the U.S. between evidence-based experts and those who distort it, noting that “there are still heroes within US agencies who are fighting a quiet, internal battle to keep good evidence in the spotlight.”